The company in question is, CR Bard Inc. (NYSE:BCR) currently with a stock price of 229.08 (-1.02% today). The market cap for CR Bard Inc. is 17164.33, and is in the sector Healthcare, and Medical Instruments & Supplies industry. The target price for CR Bard Inc. is 231. Currently CR Bard Inc. is trading with a P/E of 102.5, and a forward P/E of 20.6. Average volume for CR Bard Inc. is 475.48 and so far today it is 136968.
Performance in the last year for CR Bard Inc. has been 29.64%. For EPS growth, CR Bard Inc. has seen a growth of -52.90%, and is looking to grow in the next year to 10.74%. More long term stats show that EPS growth has been -19.80% over the last five years and could be 10.80% for the next five years. CR Bard Inc. has seen sales growth quarter over quarter at 6.60%, with EPS growth quarter over quarter at -16.70%. The 20-day simple moving average is 1.16%, with the 200-day simple moving average coming to 14.48%.
Since the IPO date for CR Bard Inc. on the 4/6/1983, CR Bard Inc. has seen performance year to date to be 22.62%. With CR Bard Inc. trading at 229.08, the dividend yield is 0.45%, and the EPS is 2.26.
So could CR Bard Inc., be undervalued? Well as said before P/E is 102.5. The PEG is 9.49, P/S is 4.95 and the P/B is at 11.73. The P/cash is 22.44, with P/free cash flow at *TBA.
CR Bard Inc. ability to deal with debt shows that the current ratio is 1.5, and the quick ratio is 1.2. This is with long term debt/equity at 0.78, and total debt/equity at 1.14.
In terms of margins, CR Bard Inc. has a gross margin of 62.20%, an operating margin of *TBA and a profit margin of *TBA.Payout ratio for CR Bard Inc. is *TBA. Return on assets come to *TBA with return on investment coming to 6.40%.
Insider ownership for CR Bard Inc., is at 0.50% and institutional ownership comes to 90.90%. Outstanding shares are at 74.16. While shares float is 73.18. The float short is currently 1.70%, and short ratio is 2.61.